Literature DB >> 19085001

High-efficiency transfer and expression of AdCMV-p53 in human cervix adenocarcinoma cells induced by subclinical-dose carbon beam radiation.

Bing Liu1, Hong Zhang, Xiaohong Luo, Yi Xie, Jifang Hao, Qingming Zhou, Xin Duan, Yanling Wang, Weiping Zhao.   

Abstract

PURPOSE: The aim of this study is to evaluate the effect of carbon-beam irradiation on adenovirus-mediated p53 transfer in human cervix adenocarcinoma.
MATERIALS AND METHODS: The HeLa cells pre-exposed to carbon-beam or gamma-ray, were infected with replication-deficient adenovirus recombinant vectors, containing human wild-type p53 (AdCMV-p53) and green fluorescent protein (GFP) (AdCMV-GFP), respectively. The GFP transfer and p53 expression were detected by flow cytometric analysis.
RESULTS: The GFP transfer frequency in C-beam with AdCMV-GFP groups was 38-50% more than that in gamma-ray with AdCMV-GFP groups. The percentage of p53 positive cells in the C-beam with AdCMV-p53 groups was 34-55.6% more than that in gamma-ray with AdCMV-p53 groups (p < 0.05), suggesting that subclinical-dose C-beam irradiation could significantly promote exogenous p53 transfer and p53 expression, and extend the duration of p53 expression in the HeLa cells. The expression of p21 increased with p53 expression in HeLa cells. The survival fractions for the 0.5-1.0 Gy C-beam with AdCMV-p53 groups were 38-43% less than those for the isodose gamma-ray with AdCMV-p53 groups, and 31-40% less than those for the C-beam only groups (p < 0.05).
CONCLUSIONS: The subclinical-dose C-beam irradiation could significantly promote the transfer and expression of exogenous p53, extend the duration of p53 expression, and enhance the suppression of p53 on cervix adenocarcinoma cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19085001     DOI: 10.1007/s00432-008-0528-6

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  37 in total

1.  P21 gene expression as an indicator for the activity of adenovirus-p53 gene therapy in non-small cell lung cancer patients.

Authors:  J L Boulay; A P Perruchoud; J Reuter; C Bolliger; R Herrmann; C Rochlitz
Journal:  Cancer Gene Ther       Date:  2000-09       Impact factor: 5.987

2.  Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer.

Authors:  J Nemunaitis; S G Swisher; T Timmons; D Connors; M Mack; L Doerksen; D Weill; J Wait; D D Lawrence; B L Kemp; F Fossella; B S Glisson; W K Hong; F R Khuri; J M Kurie; J J Lee; J S Lee; D M Nguyen; J C Nesbitt; R Perez-Soler; K M Pisters; J B Putnam; W R Richli; D M Shin; G L Walsh; J Merritt; J Roth
Journal:  J Clin Oncol       Date:  2000-02       Impact factor: 44.544

3.  A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4.

Authors:  D E Brough; A Lizonova; C Hsu; V A Kulesa; I Kovesdi
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

4.  Ionizing radiation-induced adenovirus infection is mediated by Dynamin 2.

Authors:  Jun Qian; Jiong Yang; Aleksandar F Dragovic; Eyad Abu-Isa; Theodore S Lawrence; Ming Zhang
Journal:  Cancer Res       Date:  2005-07-01       Impact factor: 12.701

5.  Adenovirus-based transfer of wild-type p53 gene increases ovarian tumor radiosensitivity.

Authors:  D Gallardo; K E Drazan; W H McBride
Journal:  Cancer Res       Date:  1996-11-01       Impact factor: 12.701

6.  WAF1, a potential mediator of p53 tumor suppression.

Authors:  W S el-Deiry; T Tokino; V E Velculescu; D B Levy; R Parsons; J M Trent; D Lin; W E Mercer; K W Kinzler; B Vogelstein
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

7.  Membrane permeability changes in gamma-irradiated muscle cells.

Authors:  D Canaday; P Li; R Weichselbaum; R D Astumian; R C Lee
Journal:  Ann N Y Acad Sci       Date:  1994-05-31       Impact factor: 5.691

8.  Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas.

Authors:  Tadashi Kamada; Hirohiko Tsujii; Hiroshi Tsuji; Tsuyoshi Yanagi; Jun-etsu Mizoe; Tadaaki Miyamoto; Hirotoshi Kato; Shigeru Yamada; Shinroku Morita; Kyousan Yoshikawa; Susumu Kandatsu; Akio Tateishi
Journal:  J Clin Oncol       Date:  2002-11-15       Impact factor: 44.544

9.  High linear energy transfer carbon radiation effectively kills cultured glioma cells with either mutant or wild-type p53.

Authors:  Y Iwadate; J Mizoe; Y Osaka; A Yamaura; H Tsujii
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-07-01       Impact factor: 7.038

10.  Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts.

Authors:  L L Nielsen; J Dell; E Maxwell; L Armstrong; D Maneval; J J Catino
Journal:  Cancer Gene Ther       Date:  1997 Mar-Apr       Impact factor: 5.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.